Paul Tudor Jones Vir Biotechnology, Inc. Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 68,113 shares of VIR stock, worth $501,992. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,113
Previous 67,904
0.31%
Holding current value
$501,992
Previous $604,000
15.56%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VIR
# of Institutions
218Shares Held
87MCall Options Held
127KPut Options Held
1.19M-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$123 Million1.03% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$96.8 Million0.0% of portfolio
-
State Street Corp Boston, MA5.63MShares$41.5 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.57MShares$26.3 Million0.63% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $978M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...